Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib. Goldberg SL. SL Goldberg, L Chen, A Guerin… - … medical research and …, 2013 - Taylor & Francis GSID: mEI241-MEsYJ
Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemia. [No authors listed] A Guerin, L Chen, K Dea, EQ Wu… - Journal of Medical …, 2014 - Taylor & Francis GSID: wFZgrPMrl1gJ
Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib. Goldberg SL. SL Goldberg, L Chen, A Guerin… - … medical research and …, 2013 - Taylor & Francis GSID: mEI241-MEsYJ
First‐line treatment selection and early monitoring patterns in chronic phase‐chronic myeloid leukemia in routine clinical practice: SIMPLICITY. [No authors listed] GSID: 8DmvKKWV2REJ
Health care resource utilization and costs in patients with chronic myeloid leukemia with better adherence to tyrosine kinase inhibitors and increased molecular …. [No authors listed] GSID: Iuh0YnO4JpQJ